NCT05127551View on ClinicalTrials.gov

Clinical Study of Glaukos® Trabecular Micro-Bypass System Model iS3 Infinite Vs. Competitor

NAActive, not recruitingINTERVENTIONAL
Enrollment

179

Participants

Timeline

Start Date

November 27, 2021

Primary Completion Date

February 29, 2024

Study Completion Date

February 28, 2025

Conditions
GlaucomaGlaucoma, Open-Angle
Interventions
DEVICE

iStent Infinite

Implantation of the iStent Infinite

DEVICE

Competitor Device

Implantation of competitor device

Trial Locations (1)

H1A 0A1

Glaukos Investigator Sites, Montreal

Sponsors
All Listed Sponsors
lead

Glaukos Corporation

INDUSTRY

NCT05127551 - Clinical Study of Glaukos® Trabecular Micro-Bypass System Model iS3 Infinite Vs. Competitor | Biotech Hunter | Biotech Hunter